Pádraig O'Sullivan
Ceist:2270. Deputy Pádraig O'Sullivan asked the Minister for Health the number of patients that could have benefitted from access to ravulizumab if positive reimbursement recommendations had been issued by the HSE for the treatment of paroxysmal nocturnal haemoglobinuria and atypical haemolytic uremic syndrome for these respective patient populations in 2021, 2022 and 2023, in tabular form; and if he will make a statement on the matter. [32236/24]
Amharc ar fhreagra